赛托瑞疗法(CYTX)

0.2077 0.0000 0.0%

今开:0.0昨收:0.2077
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4601759.0

赛托瑞疗法的最新评论

牛得草2015-09-01 11:25

$赛托瑞医疗(CYTX)$看了看半年报和电话会议纪要,感觉越来越务实了,无论硬皮病还是骨关节炎要比以前的心脏病靠谱许多,烧钱也减缓,也进入中国了,二季度竟然盈利了,一年内不需要融资,基本面在向好,回头看看股价还停留在历史低点,机会还是陷阱,不好判断,但是现在的风险要比以前参与增发的机...查看全文

来林2015-09-01 10:32

我刚刚关注了 $赛托瑞医疗(CYTX)$ ,当前价 $0.36。查看全文

hyynf2015-09-01 01:36

$赛托瑞医疗(CYTX)$ 蝇营狗苟查看全文

塞温呢莱纹2015-08-28 22:49

$赛托瑞医疗(CYTX)$ 站岗同志好多查看全文

Ethan_Snow2015-08-07 19:40

$赛托瑞医疗(CYTX)$ 2015 Q2 业绩快报产品销售收入 1.6m 去年同期 0.9m合约收入 1.8m 去年同期 0.4m每股盈利 0.03 去年同期 -0.15今晚会涨不?查看全文

Ethan_Snow2015-07-29 20:14

$赛托瑞医疗(CYTX)$ 8月6日盘后发第二季度季报,大家留意,投资日历死活找不到了,谁会就添加上吧。August 6, 2015, at 5:30PM ETSAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business upda...查看全文

Ethan_Snow2015-07-29 20:13

$赛托瑞医疗(CYTX)$ 今天任命了一位VP,负责商务发展和总法律顾问07/29/2015SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Mr.Jeremy Hayden has been appointed as General Counsel and VP of Business Development. In addition to extensive le...查看全文

利欧一桶金2015-07-29 00:45

$赛托瑞医疗(CYTX)$有没有提前布局的查看全文

Ethan_Snow2015-07-28 20:46

$赛托瑞医疗(CYTX)$ Jul 28, 2015 Cytori Licensee Kerastem Receives Conditional Approval from FDA for Alopecia TrialCytori公司许可kerastem收到FDA的批准治疗脱发的试验条件查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

赛托瑞疗法的公告

$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接

$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001564590-19-025075 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-11 AccNo: 0001564590-19-024844 Size: 64 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...

$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001564590-19-024571 Size: 40 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37